Cefuroxime And Dextrose Injection, Solution
NDC Package 0264-3114-11
Package Information
Cefuroxime And Dextrose injection is cefuroxime is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by B. Braun Medical Inc., this product is identified by NDC 0264-3114 and is authorized under FDA application NDA050780.
Identification & Billing
- RxCUI: 1665444 - cefuroxime 1.5 GM Injection
- RxCUI: 1665444 - cefuroxime 1500 MG Injection
- RxCUI: 1665449 - cefuroxime 750 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0264 - B. Braun Medical Inc.
- 0264-3114 - Cefuroxime And Dextrose
- 0264-3114-11 - 24 CONTAINER in 1 CASE / 50 mL in 1 CONTAINER
- 0264-3114 - Cefuroxime And Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0264-3114-11 identifies a specific commercial package of 24 container in 1 case / 50 ml in 1 container of Cefuroxime And Dextrose, a human prescription drug labeled by B. Braun Medical Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, solution is formulated for intravenous use and contains cefuroxime sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B. Braun Medical Inc. on February 21, 2001. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Cefuroxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.
How is this B. Braun Medical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00264311411. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.